SG11202111081XA - Compositions and methods for the cryopreservation of immune cells - Google Patents

Compositions and methods for the cryopreservation of immune cells

Info

Publication number
SG11202111081XA
SG11202111081XA SG11202111081XA SG11202111081XA SG11202111081XA SG 11202111081X A SG11202111081X A SG 11202111081XA SG 11202111081X A SG11202111081X A SG 11202111081XA SG 11202111081X A SG11202111081X A SG 11202111081XA SG 11202111081X A SG11202111081X A SG 11202111081XA
Authority
SG
Singapore
Prior art keywords
cryopreservation
compositions
methods
immune cells
immune
Prior art date
Application number
SG11202111081XA
Inventor
Yosef Refaeli
Brian Turner
Thomas Payne
Original Assignee
Taiga Biotechnologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiga Biotechnologies Inc filed Critical Taiga Biotechnologies Inc
Publication of SG11202111081XA publication Critical patent/SG11202111081XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0278—Physical preservation processes
    • A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
SG11202111081XA 2019-04-08 2020-04-07 Compositions and methods for the cryopreservation of immune cells SG11202111081XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962830950P 2019-04-08 2019-04-08
PCT/US2020/027070 WO2020210231A1 (en) 2019-04-08 2020-04-07 Compositions and methods for the cry opreservation of immune cells

Publications (1)

Publication Number Publication Date
SG11202111081XA true SG11202111081XA (en) 2021-11-29

Family

ID=72751766

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111081XA SG11202111081XA (en) 2019-04-08 2020-04-07 Compositions and methods for the cryopreservation of immune cells

Country Status (10)

Country Link
US (1) US20220142149A1 (en)
EP (1) EP3952909A4 (en)
JP (1) JP2022527117A (en)
KR (1) KR20210149746A (en)
CN (1) CN113874033A (en)
AU (1) AU2020272664A1 (en)
CA (1) CA3132857A1 (en)
IL (1) IL287010A (en)
SG (1) SG11202111081XA (en)
WO (1) WO2020210231A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022192434A1 (en) * 2021-03-10 2022-09-15 Terasaki Institute For Biomedical Innovation Methods and systems of preparing cultivated meat from blood or cellular biomass

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735522C (en) * 2008-08-28 2017-04-18 Taiga Biotechnologies, Inc. Modulators of myc, methods of using the same, and methods of identifying agents that modulate myc
AU2013292330B2 (en) * 2012-07-20 2018-07-12 Taiga Biotechnologies, Inc. Enhanced reconstitution and autoreconstitution of the hematopoietic compartment
US10583156B2 (en) * 2016-12-02 2020-03-10 Taiga Biotechnologies, Inc. Nanoparticle formulations
CN111094328A (en) * 2017-08-03 2020-05-01 泰加生物工艺学公司 Methods and compositions for treating cancer
CA3035209A1 (en) * 2017-08-03 2019-02-07 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma
US10149898B2 (en) * 2017-08-03 2018-12-11 Taiga Biotechnologies, Inc. Methods and compositions for the treatment of melanoma

Also Published As

Publication number Publication date
CN113874033A (en) 2021-12-31
EP3952909A4 (en) 2023-06-07
WO2020210231A1 (en) 2020-10-15
EP3952909A1 (en) 2022-02-16
AU2020272664A1 (en) 2021-11-04
CA3132857A1 (en) 2020-10-15
US20220142149A1 (en) 2022-05-12
JP2022527117A (en) 2022-05-30
IL287010A (en) 2021-12-01
KR20210149746A (en) 2021-12-09

Similar Documents

Publication Publication Date Title
EP3534705A4 (en) Compositions and methods for cell cryopreservation
IL280134A (en) Anti-cd112r compositions and methods
EP3472178A4 (en) Compositions and methods for the depletion of cd117+cells
IL282225A (en) Compositions and methods for immunotherapy
IL263743A (en) Compositions and methods for the depletion of cells
IL268058B1 (en) Compositions and methods for the depletion of cd137plus cells
IL274154A (en) Compositions and methods for the depletion of cd117(plus) cells
EP3700540A4 (en) Compositions and methods for the depletion of cd117+ cells
EP3601359A4 (en) Methods and compositions for modulation of immune cells
IL281015A (en) Methods and compositions for the modification of plants
EP4034253A4 (en) Compositions and methods for increasing the efficacy of immunotherapies and vaccines
IL291622A (en) Compositions comprising regulatory t cells and methods of making and using the same
EP4037711A4 (en) Compositions and methods comprising anti-nrp2 antibodies
IL286776A (en) Compositions and methods for preparing t cell compositions and uses thereof
SG11202104448WA (en) Compositions and methods
EP3717519A4 (en) Compositions and methods for the depletion of cd2+ cells
GB201815402D0 (en) Compositions and methods and uses relating thereto
IL283644A (en) Compositions and methods for immunotherapy
GB201913204D0 (en) Compositions and methods and uses relating thereto
IL282160A (en) Compositions and methods for transfecting cells
EP3675632A4 (en) Methods and compositions for the preservation of tissue
IL292872A (en) Compositions and methods for immunotherapy
GB201817444D0 (en) Methods and compositions
IL287010A (en) Compositions and methods for the cryopreservation of immune cells
GB201819987D0 (en) Methods and compositions